Lotus Eye Hospital Adjusts Valuation Amidst Underperformance and Conservative Financial Metrics
Lotus Eye Hospital & Institute has recently adjusted its evaluation, reflecting current market dynamics and financial metrics. The company shows a return on equity of 2.3 and a Price to Book Value ratio of 2.3, amidst a challenging performance compared to broader market trends.
Lotus Eye Hospital & Institute has recently undergone an adjustment in its evaluation, reflecting the company's current market dynamics and financial metrics. The stock's performance indicators reveal a return on equity of 2.3, which suggests a premium valuation, particularly highlighted by a Price to Book Value ratio of 2.3. This valuation stands out in the context of the company's recent performance, as it has not matched the broader market trends, with a reported return of -19.53% over the past year, contrasting with the BSE 500's gain of 8.58%.The company's financial metrics also indicate a low average Debt to Equity ratio of 0, which may suggest a conservative approach to leveraging. Additionally, the shareholder composition shows a predominance of non-institutional investors, which could influence the stock's market behavior and perception among potential investors.
Overall, the recent evaluation adjustment reflects a nuanced understanding of Lotus Eye Hospital's position within the Hospital & Healthcare Services sector, taking into account various performance indicators and market conditions.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
